Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Outset Medical (OM) Other Non-Current Liabilities (2019 - 2024)

Historic Other Non-Current Liabilities for Outset Medical (OM) over the last 6 years, with Q4 2024 value amounting to $2.7 million.

  • Outset Medical's Other Non-Current Liabilities rose 20078.12% to $2.7 million in Q4 2024 from the same period last year, while for Dec 2024 it was $2.7 million, marking a year-over-year increase of 20078.12%. This contributed to the annual value of $2.7 million for FY2024, which is 20078.12% up from last year.
  • Per Outset Medical's latest filing, its Other Non-Current Liabilities stood at $2.7 million for Q4 2024, which was up 20078.12% from $2.2 million recorded in Q3 2024.
  • In the past 5 years, Outset Medical's Other Non-Current Liabilities registered a high of $2.7 million during Q4 2024, and its lowest value of $113000.0 during Q4 2022.
  • Over the past 5 years, Outset Medical's median Other Non-Current Liabilities value was $700500.0 (recorded in 2021), while the average stood at $881388.9.
  • Per our database at Business Quant, Outset Medical's Other Non-Current Liabilities crashed by 8432.73% in 2022 and then soared by 69292.04% in 2023.
  • Outset Medical's Other Non-Current Liabilities (Quarter) stood at $240000.0 in 2020, then surged by 200.42% to $721000.0 in 2021, then plummeted by 84.33% to $113000.0 in 2022, then surged by 692.92% to $896000.0 in 2023, then surged by 200.78% to $2.7 million in 2024.
  • Its Other Non-Current Liabilities stands at $2.7 million for Q4 2024, versus $2.2 million for Q3 2024 and $1.8 million for Q2 2024.